Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
Aminoglycosides, tetracyclines, and certain other antibiotics may alter gut microbiota composition, potentially affecting the small amount of vitamin B12 that is produced by colonic bacteria, though this is generally not clinically significant for patients receiving injectable B12 supplementation
The sixth embodiment of the present invention provides an improved process for the preparation of compound of formula-3 (Semaglutide side chain), comprising
Healthcare providers should evaluate for adverse effects, review medication adherence, and reinforce lifestyle modifications including nutrition and physical activity
The Effect of Semaglutide on Blood Pressure in Patients without Diabetes: A Systematic Review and Meta-Analysis